🇺🇸 FDA
Patent

US 10308617

Triazole benzamide derivatives and the compositions and methods of treatment regarding the same

granted A61PA61P35/00A61P35/02

Quick answer

US patent 10308617 (Triazole benzamide derivatives and the compositions and methods of treatment regarding the same) held by AN2H DISCOVERY LIMITED expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AN2H DISCOVERY LIMITED
Grant date
Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P35/00, A61P35/02